Oppenheimer & CO Inc Baxter International Inc Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Baxter International Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 36,635 shares of BAX stock, worth $1.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,635
Previous 31,930 14.74%
Holding current value
$1.2 Million
Previous $1.07 Million 30.24%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$32.85 - $40.26 $154,559 - $189,423
4,705 Added 14.74%
36,635 $1.39 Million
Q2 2024

Aug 07, 2024
SELL
$32.87 - $43.55 $37,011 - $49,037
-1,126 Reduced 3.41%
31,930 $1.07 Million
Q1 2024

May 06, 2024
BUY
$37.88 - $43.77 $1 Million - $1.16 Million
26,483 Added 402.91%
33,056 $1.41 Million
Q4 2023

Feb 13, 2024
SELL
$31.71 - $38.95 $243,913 - $299,603
-7,692 Reduced 53.92%
6,573 $254,000
Q3 2023

Nov 07, 2023
SELL
$37.32 - $49.29 $172,903 - $228,360
-4,633 Reduced 24.52%
14,265 $538,000
Q2 2023

Aug 02, 2023
BUY
$39.98 - $47.68 $457,531 - $545,649
11,444 Added 153.53%
18,898 $860,000
Q1 2023

May 10, 2023
BUY
$37.58 - $52.57 $67,117 - $93,890
1,786 Added 31.51%
7,454 $302,000
Q4 2022

Feb 07, 2023
SELL
$49.7 - $57.71 $571,848 - $664,011
-11,506 Reduced 67.0%
5,668 $288,000
Q3 2022

Nov 14, 2022
SELL
$53.86 - $66.8 $13,141 - $16,299
-244 Reduced 1.4%
17,174 $925,000
Q2 2022

Aug 08, 2022
SELL
$63.83 - $80.0 $107,042 - $134,160
-1,677 Reduced 8.78%
17,418 $1.12 Million
Q1 2022

May 12, 2022
BUY
$76.85 - $89.45 $2,459 - $2,862
32 Added 0.17%
19,095 $1.48 Million
Q4 2021

Feb 02, 2022
BUY
$74.57 - $87.19 $37,956 - $44,379
509 Added 2.74%
19,063 $1.64 Million
Q3 2021

Nov 12, 2021
SELL
$73.77 - $83.61 $176,015 - $199,493
-2,386 Reduced 11.39%
18,554 $1.49 Million
Q2 2021

Aug 03, 2021
BUY
$80.5 - $88.01 $40,813 - $44,621
507 Added 2.48%
20,940 $1.69 Million
Q1 2021

May 10, 2021
BUY
$76.38 - $86.03 $36,891 - $41,552
483 Added 2.42%
20,433 $1.72 Million
Q4 2020

Feb 11, 2021
SELL
$75.39 - $82.36 $19,601 - $21,413
-260 Reduced 1.29%
19,950 $1.6 Million
Q3 2020

Nov 13, 2020
BUY
$78.33 - $90.73 $41,906 - $48,540
535 Added 2.72%
20,210 $1.63 Million
Q2 2020

Aug 11, 2020
BUY
$78.66 - $94.14 $145,599 - $174,253
1,851 Added 10.38%
19,675 $1.69 Million
Q1 2020

May 08, 2020
SELL
$71.57 - $93.3 $74,504 - $97,125
-1,041 Reduced 5.52%
17,824 $1.45 Million
Q4 2019

Feb 07, 2020
SELL
$76.7 - $88.45 $46,250 - $53,335
-603 Reduced 3.1%
18,865 $1.58 Million
Q3 2019

Oct 31, 2019
BUY
$81.4 - $89.78 $9,849 - $10,863
121 Added 0.63%
19,468 $1.7 Million
Q2 2019

Aug 09, 2019
SELL
$73.44 - $82.41 $99,584 - $111,747
-1,356 Reduced 6.55%
19,347 $1.58 Million
Q1 2019

Apr 24, 2019
SELL
$64.48 - $81.31 $53,196 - $67,080
-825 Reduced 3.83%
20,703 $1.68 Million
Q4 2018

Jan 29, 2019
SELL
$61.45 - $77.8 $74,108 - $93,826
-1,206 Reduced 5.3%
21,528 $1.42 Million
Q3 2018

Oct 26, 2018
SELL
$70.71 - $77.75 $51,901 - $57,068
-734 Reduced 3.13%
22,734 $1.75 Million
Q2 2018

Aug 10, 2018
BUY
$63.43 - $75.41 $29,621 - $35,216
467 Added 2.03%
23,468 $1.73 Million
Q1 2018

May 01, 2018
BUY
$62.56 - $72.26 $65,875 - $76,089
1,053 Added 4.8%
23,001 $1.5 Million
Q4 2017

Feb 07, 2018
SELL
$61.45 - $66.05 $70,298 - $75,561
-1,144 Reduced 4.95%
21,948 $1.42 Million
Q3 2017

Nov 09, 2017
BUY
$59.5 - $64.61 $1.37 Million - $1.49 Million
23,092
23,092 $1.45 Million

Others Institutions Holding BAX

# of Institutions
1,006
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email